High materiality9/10
Prime Medicine initiated with an Outperform at BMO Capital
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BMO Capital initiates Prime Medicine (PRME) with Outperform; Target $9; Current price $3.05.
- Outperform; PT $9; current price $3.05
Key facts
- 01
Target: $9
- 02
Posted price: $3.05
- 03
Analyst firm: BMO Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.